Biomaterial Database

[Platelet aggregation and various coagulation parameters in liver cirrhosis]. 1984

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Twenty eight patients affected by liver cirrhosis were studied in comparison with 44 control subjects, matched for age. The following parameters were carried out: a) platelet aggregation (by Born's method) induced by increasing concentrations of ADP and epinephrine; b) PF3 ( Spaet - Cintron method) and antithrombin III, aPTT, prothrombin ratio, fibrinogen, platelet count. Platelet aggregation and availability of PF3 are lower in cirrhotic patients, suggesting an intrinsic defect of platelets. Moreover prolongation of aPTT and prothrombin ratio, lower levels of antithrombin III, fibrinogen and platelet count were detected.

UI	MeSH Term	Description	Entries
D008103	Liver Cirrhosis	Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.	Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D010974	Platelet Aggregation	The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.	Aggregation, Platelet
D010976	Platelet Count	The number of PLATELETS per unit volume in a sample of venous BLOOD.	Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D010977	Platelet Factor 3	A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION.	PF 3,Factor 3, Platelet
D011516	Prothrombin	A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.	Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D002784	Cholesterol	The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.	Epicholesterol
D004837	Epinephrine	The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.	Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260	Female		Females

Related Publications

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

[Behavior of various blood coagulation parameters and of platelet aggregation in normolipidemic patients with arteriosclerosis and hypertension].

January 1976, Bollettino della Societa italiana di cardiologia,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis.

July 2018, Platelets,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Platelet aggregation and coagulation and fibrinolysis parameters in both portal and systemic circulations in patients with cirrhosis and hepatocellular carcinoma.

January 2001, Hepatology research : the official journal of the Japan Society of Hepatology,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

[Coagulation, fibrinolysis and various diseases: hepatitis and liver cirrhosis].

May 1974, Nihon rinsho. Japanese journal of clinical medicine,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

[Effect of Glyvenol on platelet adhesiveness and various coagulation parameters].

July 1969, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Coagulation and platelet aggregation in atherosclerosis.

January 1988, Acta cardiologica. Supplementum,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Platelet aggregation in patients with Laennec's cirrhosis of the liver.

June 1967, The New England journal of medicine,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Platelet aggregation and portal cirrhosis.

February 1977, Archives of internal medicine,

S Calabrese, and C Giansante, and C Sammartini, and A Benedetti

Platelet aggregation in portal cirrhosis.

March 1976, Archives of internal medicine,